Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 5—May 2017
Research

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China

Fuqiang Cui1, Lipin Shen1, Li Li1, Huaqing Wang1, Fuzhen Wang1, Shengli Bi, Jianhua Liu, Guomin Zhang, Zijian FengComments to Author , Hui Zheng, Xiaojin Sun, Ning Miao, and Zundong Yin
Author affiliations: Peking University Health Science Center, Beijing, China (F. Cui); Chinese Center for Disease Control and Prevention, Beijing (L. Shen, L. Li, H. Wang, F. Wang, S. Bi, G. Zhang, F. Wang, H. Zheng, X. Sun, N. Miao, Z. Yin, Z. Feng, X. Liang, Y. Wang); Guangzhou Center for Disease Control and Prevention, Guangzhou, China (J. Liu)

Main Article

Figure 1

Study eligibility and select characteristics of persons participating in 1992, 2006, and 2014 national serosurveys for hepatitis B virus, China. DSPs, disease surveillance points.

Figure 1. Study eligibility and select characteristics of persons participating in 1992, 2006, and 2014 national serosurveys for hepatitis B virus, China. DSPs, disease surveillance points.

Main Article

1These authors contributed equally to this article.

Page created: April 14, 2017
Page updated: April 14, 2017
Page reviewed: April 14, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external